Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Technological advancements for the development of stem cell-based models for hepatotoxicity testing

A. Natale, K. Vanmol, A. Arslan, S. Van Vlierberghe, P. Dubruel, J. Van Erps, H. Thienpont, M. Buzgo, J. Boeckmans, J. De Kock, T. Vanhaecke, V. Rogiers, RM. Rodrigues,

. 2019 ; 93 (7) : 1789-1805. [pub] 20190429

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025785

Stem cells are characterized by their self-renewal capacity and their ability to differentiate into multiple cell types of the human body. Using directed differentiation strategies, stem cells can now be converted into hepatocyte-like cells (HLCs) and therefore, represent a unique cell source for toxicological applications in vitro. However, the acquired hepatic functionality of stem cell-derived HLCs is still significantly inferior to primary human hepatocytes. One of the main reasons for this is that most in vitro models use traditional two-dimensional (2D) setups where the flat substrata cannot properly mimic the physiology of the human liver. Therefore, 2D-setups are progressively being replaced by more advanced culture systems, which attempt to replicate the natural liver microenvironment, in which stem cells can better differentiate towards HLCs. This review highlights the most recent cell culture systems, including scaffold-free and scaffold-based three-dimensional (3D) technologies and microfluidics that can be employed for culture and hepatic differentiation of stem cells intended for hepatotoxicity testing. These methodologies have shown to improve in vitro liver cell functionality according to the in vivo liver physiology and allow to establish stem cell-based hepatic in vitro platforms for the accurate evaluation of xenobiotics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025785
003      
CZ-PrNML
005      
20201222160405.0
007      
ta
008      
201125s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00204-019-02465-y $2 doi
035    __
$a (PubMed)31037322
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Natale, Alessandra $u Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Brussels, Belgium.
245    10
$a Technological advancements for the development of stem cell-based models for hepatotoxicity testing / $c A. Natale, K. Vanmol, A. Arslan, S. Van Vlierberghe, P. Dubruel, J. Van Erps, H. Thienpont, M. Buzgo, J. Boeckmans, J. De Kock, T. Vanhaecke, V. Rogiers, RM. Rodrigues,
520    9_
$a Stem cells are characterized by their self-renewal capacity and their ability to differentiate into multiple cell types of the human body. Using directed differentiation strategies, stem cells can now be converted into hepatocyte-like cells (HLCs) and therefore, represent a unique cell source for toxicological applications in vitro. However, the acquired hepatic functionality of stem cell-derived HLCs is still significantly inferior to primary human hepatocytes. One of the main reasons for this is that most in vitro models use traditional two-dimensional (2D) setups where the flat substrata cannot properly mimic the physiology of the human liver. Therefore, 2D-setups are progressively being replaced by more advanced culture systems, which attempt to replicate the natural liver microenvironment, in which stem cells can better differentiate towards HLCs. This review highlights the most recent cell culture systems, including scaffold-free and scaffold-based three-dimensional (3D) technologies and microfluidics that can be employed for culture and hepatic differentiation of stem cells intended for hepatotoxicity testing. These methodologies have shown to improve in vitro liver cell functionality according to the in vivo liver physiology and allow to establish stem cell-based hepatic in vitro platforms for the accurate evaluation of xenobiotics.
650    _2
$a alternativy testů na zvířatech $x metody $7 D000826
650    _2
$a buněčné kultury $7 D018929
650    _2
$a buněčná diferenciace $x účinky léků $7 D002454
650    _2
$a lékové postižení jater $x etiologie $7 D056486
650    _2
$a hepatocyty $x cytologie $x účinky léků $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a játra $x účinky léků $7 D008099
650    _2
$a kmenové buňky $x cytologie $x účinky léků $7 D013234
650    _2
$a xenobiotika $x toxicita $7 D015262
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Vanmol, Koen $u Brussels Photonics (B-PHOT), Vrije Universiteit Brussel and Flanders Make, Brussels, Belgium.
700    1_
$a Arslan, Aysu $u Polymer Chemistry and Biomaterials Group (PBM), Centre of Macromolecular Chemistry, Ghent University, Ghent, Belgium.
700    1_
$a Van Vlierberghe, Sandra $u Brussels Photonics (B-PHOT), Vrije Universiteit Brussel and Flanders Make, Brussels, Belgium. Polymer Chemistry and Biomaterials Group (PBM), Centre of Macromolecular Chemistry, Ghent University, Ghent, Belgium.
700    1_
$a Dubruel, Peter $u Polymer Chemistry and Biomaterials Group (PBM), Centre of Macromolecular Chemistry, Ghent University, Ghent, Belgium.
700    1_
$a Van Erps, Jürgen $u Brussels Photonics (B-PHOT), Vrije Universiteit Brussel and Flanders Make, Brussels, Belgium.
700    1_
$a Thienpont, Hugo $u Brussels Photonics (B-PHOT), Vrije Universiteit Brussel and Flanders Make, Brussels, Belgium.
700    1_
$a Buzgo, Matij $u Inocure, Prague, Czech Republic.
700    1_
$a Boeckmans, Joost $u Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Brussels, Belgium.
700    1_
$a De Kock, Joery $u Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Brussels, Belgium.
700    1_
$a Vanhaecke, Tamara $u Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Brussels, Belgium.
700    1_
$a Rogiers, Vera $u Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Brussels, Belgium.
700    1_
$a Rodrigues, Robim M $u Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Brussels, Belgium. robim.marcelino.rodrigues@vub.be.
773    0_
$w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 93, č. 7 (2019), s. 1789-1805
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31037322 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222160401 $b ABA008
999    __
$a ok $b bmc $g 1599930 $s 1116471
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 93 $c 7 $d 1789-1805 $e 20190429 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...